AGMEGMLonza Announces Results of the 2025 Annual General Meeting – All Motions Proposed by Board of Directors Approved 09.05.2025 / 16:30 CET/CEST Jean-Marc Huët was re-elected as Chair of the Board ...

CCSNH’s ApprenticeshipNH and Lonza are launching a new biomanufacturing apprenticeship program. Pictured are, from left to right, Alex Hackathorn, Lonza Senior Aseptic Training Specialist in ...

Lonza said it doesn't expect a material financial impact from potential tariffs and backed its full-year guidance for its contract development and manufacturing business. The Swiss life-science ...

Basel-based Lonza joined CMAC, a center for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture. Based at the ...

Ethris has partnered with contract development and manufacturing organisation Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory conditions.

Ladies and gentlemen, welcome to the Lonza Q1 2025 Qualitative Update Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. I would like to remind you that all participants will ...

The extended agreement will expand the dedicated bioconjugation footprint for the customer through the construction of a new bioconjugation suite at Lonza’s Ibex ® Biopark in Visp (CH). In addition, ...